Jebediah Ledell - 01 Dec 2021 Form 3 Insider Report for AVEO PHARMACEUTICALS, INC.

Role: Chief Operating Officer
Signature: /s/ Danielle Holland, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 01 Dec 2021
Net transactions value: $0
Form type: 3
Filing time: 03 Dec 2021, 07:43:16 UTC
Next filing: 17 Feb 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney